Related Experiment Video
Updated: May 23, 2026
08:06
Mixed Reality Assisted Radical Endoscopic Thyroidectomy
Published on: January 31, 2025
[Should thyroxine treatment be discontinued for four weeks before I(131) thyroid ablation?]
Reyes Luna1, Manuel Penín, Inés Seoane
1Servicio de Endocrinología y Nutrición, Complexo Hospitalario Universitario de Vigo, Vigo, Pontevedra, España.
Summary
Thyroid hormone withdrawal before radioactive iodine ablation can be shortened. Most patients achieve adequate TSH levels for ablation within 14 days of stopping levothyroxine, with 21 days sufficient for all.
Area of Science:
- Endocrinology
- Nuclear Medicine
- Thyroid Cancer Management
Background:
- Standard practice involves four weeks of thyroxine withdrawal before radioactive iodine (131I) ablation.
- This withdrawal period often leads to symptomatic hypothyroidism.
- Recombinant human thyroid-stimulating hormone (rhTSH) is an alternative but faced availability issues in 2012.
Purpose of the Study:
- To determine the optimal duration of thyroxine withdrawal before 131I ablation.
- To evaluate the time course of TSH and free T4 (FT4) levels after thyroidectomy or thyroxine withdrawal.
Main Methods:
- Plasma TSH and FT4 levels were monitored on days 7, 14, 21, and 28 post-thyroidectomy (12 patients) or thyroxine discontinuation (20 patients).
- Statistical analysis included Mann-Whitney U tests for quantitative data and Chi-square tests for nominal data.
Main Results:
- By day 14, 71% of patients had TSH levels ≥ 30 μIU/mL (66% thyroidectomy, 75% thyroxine withdrawal).
- By day 21, 91% (thyroidectomy) and 100% (thyroxine withdrawal) achieved TSH levels ≥ 30 μIU/mL.
- On day 14, most patients exhibited FT4 levels below the normal range.
Conclusions:
- Four weeks of thyroxine withdrawal is unnecessary.
- Fourteen days is adequate for TSH elevation in most patients undergoing 131I ablation.
- Twenty-one days is sufficient for virtually all patients, minimizing hypothyroidism symptoms.
Related Concept Videos
01:20Synthesis and Regulation of Thyroid Hormones
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
01:25Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
01:27Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
01:24Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
01:18Functions of Thyroid Hormones
The thyroid hormone (TH) plays a pivotal role in the intricate orchestration of physiological processes, exerting profound effects on development, metabolism, and homeostasis throughout different life stages.
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
01:27Goiter
Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...